Benoit Hendrickx MD, PhD
Appearances
DateNovember 21, 2024Alluzience (abobotulinumtoxinA RTU; Ipsen, Paris, France and Galderma SA, Lausanne, Switzerland) is the first readyto-use (RTU) botulinum toxin type A liquid solution approved for the treatment of glabellar lines in Europe…Speakers
Benjamin Ascher, MDAlessio Redaelli, MDBenoit Hendrickx, MD, PhDIvano Iozzo, MDAlicia Milotich, MDBeatriz Molina, MDHugues Cartier, MDPhilippe Picaut, PharmDInna Prygova, MD
